References
- DeMonchy J GR, Daufman H F, Venge P, Koeter G H, Jansen H M, Sluiter H J, DeVries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373–380
- Schats M, Wasserman S, Patterson R. The eosinophil and the lung. Arch Intern Med 1982; 142: 1515–1519
- Dahl R, Venge P. Role of eosinophil in bronchial asthma. Eur J Respir Dis 1982; 122: 23–28, Suppl
- Weller P F. The immunobiology of eosinophils. N Engl J Med 1991; 324: 1110–1116
- Tamura N, Agrawal D K, Townley R G. Leukotriene C4 production from human eosiniphils in vitro: Role of eosinophil chemotactic factors on eosinophil activation. J Immunol 1988; 141: 4291–1297
- Agrawal D K. Platelet-activating factor receptors in the airways. Inflammatory Cells and Mediators in Bronchial Asthma, D K Agrawal, R G Townley. CRC Press, Boca Raton, FL 1991; 171–206
- DeSimone C, Donelli G, Melli D, Rosati F, Sorice F. Human eosinophils and parasitic diseases. II. Characterization of two cell fractions isolated at different densities. Clin Exp Immunol 1982; 48: 249–255
- Gartner I. Separation of human eosinophils in density gradients of polyvinylpyrrolidone coated silica gel (Percoll). Immunology 1980; 40: 133–136
- Fukuda T, Dunnette S L, Reed C, Ackerman S J, Peters M S, Gleich G. Increased number of hypodense eosinophils in the blood of patients with bronchial asthma. Am Rev Respir Dis 1985; 132: 981–987
- Bass D A, Grove W H, Lewis J C, Szejda P, Chatelet L R, McCall C E. Comparison of human eosinophils from normals and patients with eosinophilia. J Clin Invest 1980; 66: 1265–1273
- Agrawal D K, Numao T. Transmembrane signaling in eosinophils. Eosinophils, S Makino, T Fukuda. CRC Press, Boca Raton, FL 1993; 171–192
- Kajita T, Yui Y, Mita H, Taniguchi N, Saito H, Mishima T, Shida T. Release of leukotriene C4 from human eosinophils and its relation to the cell density. Int Arch Allergy Appl Immunol 1985; 75: 406–410
- Cuss F M, Dixon C MS, Barnes P J. Effect of inhaled platelet-activating factor on pulmonary function and bronchial responsiveness in man. Lancet 1986; 2: 189–192
- Townley R G, Hopp R J, Agrawal D K, Bewtra A K. Platelet-activating factor and airway reactivity. J Allergy Clin Immunol 1989; 83: 997–1012
- Numao T, Agrawal D K. Neuropeptides modulate human eosinophil chemotaxis. J Immunol 1992; 149: 3309–3315
- Tamura N, Agrawal D K, Suliaman F A, Townley R G. Effects of platelet-activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem Biophys Res Commun 1987; 142: 638–644
- Frick W E, Sedgwick J B, Busse W W. The appearance of hypodense eosinophils (HE) in late phase asthma. J Allergy Clin Immunol 1988; 81: 208–214
- Fukuda T, Gleich G J. Heterogeneity of human eosinophils. J Allergy Clin Immunol 1989; 83: 369–373
- Shult P A, Lega M, Jadidi S, Vrtis R, Warner T, Graziano F, Busse W W. The presence of hypodense eosinophils and diminished chemiluminescence response in asthma. J Allergy Clin Immunol 1988; 81: 429–437
- Olofsson T, Gartner I, Olsson I. Separation of human bone marrow cells in density gradient of polyvinylpyrrolidone coated silica gel (Percoll). Scand J Haematol 1980; 24: 254–262
- Peters M S, Gleich G J, Dunnette S L, Fukuda T. Ultra-structural study of eosinophils from patients with the hypereosinophilic syndrome: A morphological basis of hypodense eosinophils. Blood 1988; 71: 780–785
- Sedgwick J B, Frick W E, Sondel P M, Busse W W. The appearance of hypodense eosinophils (HE) during interleukin-2 (IL-2) treatment. J Allergy Clin Immunol 1988; 81: 208–214
- Tai P C, Bakes D M, Barkans J R, Spry C JF. Plasma membrane antigens on light density and activated human blood eosinophils. Clin Exp Immunol 1985; 60: 427–436
- Kloprogge E, De Leeuw A J, De Monchy J GR, Kauffman H F. Hypodense eosinophilic granulocytes in normal individuals and patients with asthma: Generation of hypodense cell populations in vitro. J Allergy Clin Immunol 1989; 83: 393–100